• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简短报告:背景很重要:在东非艾滋病毒血清学不一致的夫妇中,暴露前预防药物的依从性与性行为有关。

Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa.

作者信息

Haberer Jessica E, Ngure Kenneth, Muwonge Timothy, Mugo Nelly, Katabira Elly, Heffron Renee, Musinguzi Nicholas, Bangsberg David R, Celum Connie, Baeten Jared M

机构信息

*MGH Global Health, Boston, MA; †Kenya Medical Research Institute, Thika, Kenya; ‡Infectious Disease Institute, Kampala, Uganda; §Department of Global Health, University of Washington, Seattle, WA; ‖Mbarara University of Science and Technology, Mbarara, Uganda; and ¶Oregon Health and Sciences University-Portland State University School of Public Health, Portland, OR.

出版信息

J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):488-492. doi: 10.1097/QAI.0000000000001548.

DOI:10.1097/QAI.0000000000001548
PMID:28961676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5680116/
Abstract

BACKGROUND

Short message service (SMS) surveys are a promising tool for understanding whether preexposure prophylaxis (PrEP) adherence aligns with risk for HIV acquisition-a concept known as prevention-effective adherence.

METHODS

The Partners Demonstration Project was an open-label study of integrated PrEP and antiretroviral therapy (ART) delivery among high-risk HIV serodiscordant couples in East Africa. HIV-uninfected partners were offered PrEP until their HIV-infected partner had taken ART for ≥6 months. At 2 study sites, HIV-uninfected partners were offered enrollment into the Partners Mobile Adherence to PrEP (PMAP) substudy based on ongoing PrEP use, personal cell phone ownership, and ability to use SMS. SMS surveys asked about PrEP adherence and sexual activity in the previous 24 hours; these surveys were sent daily for the 7 days before and 7 days after routine study visits in the Partners Demonstration Project.

RESULTS

The PMAP substudy enrolled 373 HIV-uninfected partners; 69% were men and mean age was 31 years. Participants completed 17,030 of 23,056 SMS surveys sent (74%) with a mean of 47 surveys per participant over 9.8 months of follow-up. While HIV-infected partner use of ART was <6 months, mean reported PrEP adherence was 92% on surveys concurrently reporting sex within the serodiscordant partnership, and 84% on surveys reporting no sex (P < 0.001).

DISCUSSION

SMS surveys provided daily assessment of concurrent PrEP adherence and sexual behavior. Higher PrEP adherence was temporally associated with increased risk for HIV acquisition.

摘要

背景

短信服务(SMS)调查是一种很有前景的工具,可用于了解暴露前预防(PrEP)的依从性是否与获得艾滋病毒的风险相符——这一概念被称为预防有效依从性。

方法

伙伴示范项目是一项在东非高危艾滋病毒血清学不一致的夫妇中开展的关于综合PrEP和抗逆转录病毒疗法(ART)给药的开放标签研究。未感染艾滋病毒的伴侣可获得PrEP,直至其感染艾滋病毒的伴侣接受ART治疗≥6个月。在2个研究地点,根据持续使用PrEP、拥有个人手机以及使用短信的能力,邀请未感染艾滋病毒的伴侣参加伙伴PrEP移动依从性(PMAP)子研究。短信调查询问了前24小时内的PrEP依从性和性行为;在伙伴示范项目的常规研究访视前7天和访视后7天每天发送这些调查。

结果

PMAP子研究招募了373名未感染艾滋病毒的伴侣;69%为男性,平均年龄为31岁。在发送的23,056份短信调查中,参与者完成了17,030份(74%),在9.8个月的随访中,每位参与者平均完成47份调查。在艾滋病毒感染伴侣接受ART治疗<6个月时,在同时报告血清学不一致伴侣关系内有性行为的调查中,报告的PrEP平均依从率为92%,在报告无性行为的调查中为84%(P<0.001)。

讨论

短信调查提供了对PrEP依从性和性行为的每日评估。较高的PrEP依从性在时间上与获得艾滋病毒的风险增加相关。

相似文献

1
Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa.简短报告:背景很重要:在东非艾滋病毒血清学不一致的夫妇中,暴露前预防药物的依从性与性行为有关。
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):488-492. doi: 10.1097/QAI.0000000000001548.
2
Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.肯尼亚和乌干达艾滋病毒血清学不一致伴侣暴露前预防示范项目中依从性与艾滋病毒感染风险的比对:预防有效依从性的前瞻性分析
J Int AIDS Soc. 2017 Jul 25;20(1):21842. doi: 10.7448/IAS.20.1.21842.
3
Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study.短消息服务 (SMS) 调查在东非的 HIV 阴性的性伴一方感染 HIV 的异性恋伴侣中,评估暴露前预防 (PrEP) 服药依从性和性行为是高度可接受的:一项混合方法研究。
AIDS Behav. 2019 May;23(5):1267-1276. doi: 10.1007/s10461-018-2326-8.
4
Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.关于抗逆转录病毒疗法与暴露前预防联合用于预防艾滋病毒的艾滋病毒血清学不一致伴侣咨询框架
J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1(Suppl 1):S15-S22. doi: 10.1097/QAI.0000000000001210.
5
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.抗逆转录病毒预防 HIV 感染的依从性:东非血清学不一致夫妇临床试验中的子研究队列。
PLoS Med. 2013;10(9):e1001511. doi: 10.1371/journal.pmed.1001511. Epub 2013 Sep 10.
6
Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness.肯尼亚实施针对 HIV 血清不一致夫妇的综合安全性行为干预措施:参与度、使用情况和效果。
J Int AIDS Soc. 2019 Apr;22(4):e25261. doi: 10.1002/jia2.25261.
7
PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.PrEP 停药与预防有效依从性:乌干达 HIV 血清不一致夫妇中 PrEP 用户的经验。
J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):265-274. doi: 10.1097/QAI.0000000000002139.
8
Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy.东非艾滋病毒血清学不一致夫妇对艾滋病治疗(ART)建议及针对性暴露前预防(PrEP)使用的依从性:“PrEP作为通向ART的桥梁”策略
BMC Public Health. 2020 Oct 28;20(1):1621. doi: 10.1186/s12889-020-09712-3.
9
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.向HIV-1血清学不一致的夫妇综合提供抗逆转录病毒治疗和暴露前预防:在肯尼亚和乌干达进行的一项前瞻性实施研究。
PLoS Med. 2016 Aug 23;13(8):e1002099. doi: 10.1371/journal.pmed.1002099. eCollection 2016 Aug.
10
Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa.东非地区男女性人群中抑郁对口服暴露前预防(PrEP)依从性的影响。
J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):330-338. doi: 10.1097/QAI.0000000000001821.

引用本文的文献

1
Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes.增强乌干达渔民的口服暴露前预防(PrEP)实施:试点干预结果。
AIDS Behav. 2024 Oct;28(10):3512-3524. doi: 10.1007/s10461-024-04432-w. Epub 2024 Jul 19.
2
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).南非、乌干达和津巴布韦青春期少女和年轻女性对口服暴露前预防 (PrEP) 或双夫定阴道环用于 HIV 预防的基线偏好(MTN-034/IPM-045 研究)。
PLoS One. 2023 Jun 23;18(6):e0287525. doi: 10.1371/journal.pone.0287525. eCollection 2023.
3

本文引用的文献

1
Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.关于抗逆转录病毒疗法与暴露前预防联合用于预防艾滋病毒的艾滋病毒血清学不一致伴侣咨询框架
J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1(Suppl 1):S15-S22. doi: 10.1097/QAI.0000000000001210.
2
Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.大型综合医疗保健系统中用于预防HIV的暴露前预防:依从性、肾脏安全性及停药情况
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546. doi: 10.1097/QAI.0000000000001129.
3
Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study.
肯尼亚一项暴露前预防试验中年轻女性的动态感知艾滋病毒风险与性行为:一项定性研究
Front Reprod Health. 2021 Aug 12;3:637869. doi: 10.3389/frph.2021.637869. eCollection 2021.
4
Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.HIV 暴露前预防的启动、停止和重新开始:正在实施的策略。
Lancet HIV. 2020 Oct;7(10):e721-e730. doi: 10.1016/S2352-3018(20)30203-4. Epub 2020 Aug 27.
5
Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa.东非 HIV 阴性的血清不一致伴侣中的性行为和感知 HIV 风险。
AIDS Behav. 2020 Jul;24(7):2082-2090. doi: 10.1007/s10461-019-02773-5.
6
Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach.使用马尔可夫建模方法评估人口统计学和社会行为因素对艾滋病病毒暴露前预防依从性的影响。
Front Pharmacol. 2019 Jul 12;10:785. doi: 10.3389/fphar.2019.00785. eCollection 2019.
7
HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.HIV-1 自我检测以提高暴露前预防措施的提供效率:肯尼亚的一项随机试验。
Trials. 2019 Jul 4;20(1):396. doi: 10.1186/s13063-019-3521-2.
8
Tenofovir Plasma Concentration from Preexposure Prophylaxis at the Time of Potential HIV Exposure: a Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa.在潜在 HIV 暴露时的暴露前预防中,替诺福韦的血浆浓度:涉及东非血清学不一致夫妇的群体药代动力学建模和模拟研究。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00446-19. Print 2019 Aug.
9
A clinic-based tablet application to support safer conception among HIV serodiscordant couples in Kenya: feasibility and acceptability study.肯尼亚一款基于诊所的平板电脑应用程序,用于支持HIV血清学不一致夫妇实现更安全受孕:可行性与可接受性研究。
Mhealth. 2019 Feb 14;5:4. doi: 10.21037/mhealth.2019.01.04. eCollection 2019.
10
Vulnerable Periods: Characterizing Patterns of Sexual Risk and Substance Use During Lapses in Adherence to HIV Pre-exposure Prophylaxis Among Men Who Have Sex With Men.易感染期:男男性行为者中断 HIV 暴露前预防用药期间性行为风险和物质使用模式的特征。
J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):276-283. doi: 10.1097/QAI.0000000000001914.
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
向HIV-1血清学不一致的夫妇综合提供抗逆转录病毒治疗和暴露前预防:在肯尼亚和乌干达进行的一项前瞻性实施研究。
PLoS Med. 2016 Aug 23;13(8):e1002099. doi: 10.1371/journal.pmed.1002099. eCollection 2016 Aug.
4
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.一种转化药理学方法,用于预测使用富马酸替诺福韦二吡呋酯联合或不联合恩曲他滨对男性和女性进行暴露前预防艾滋病毒的结果。
J Infect Dis. 2016 Jul 1;214(1):55-64. doi: 10.1093/infdis/jiw077. Epub 2016 Feb 24.
5
The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.暴露前预防的变革;从临床试验到项目实施。
Curr Opin HIV AIDS. 2016 Jan;11(1):80-6. doi: 10.1097/COH.0000000000000224.
6
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.与市级和社区性健康服务相结合的HIV感染暴露前预防
JAMA Intern Med. 2016 Jan;176(1):75-84. doi: 10.1001/jamainternmed.2015.4683.
7
Disclosure of pharmacokinetic drug results to understand nonadherence.披露药代动力学药物结果以了解不依从情况。
AIDS. 2015 Oct 23;29(16):2161-71. doi: 10.1097/QAD.0000000000000801.
8
Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066).在健康志愿者中直接观察给药后替诺福韦-恩曲他滨的剂量频率范围药代动力学研究,以建立依从性基准(HPTN 066)
AIDS Res Hum Retroviruses. 2016 Jan;32(1):32-43. doi: 10.1089/AID.2015.0182. Epub 2015 Oct 15.
9
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm.界定艾滋病病毒暴露前预防的成功:一种预防有效依从性范式。
AIDS. 2015 Jul 17;29(11):1277-85. doi: 10.1097/QAD.0000000000000647.
10
A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa.在肯尼亚邦多和南非比勒陀利亚,描述分析了 FEM-PrEP 参与者中 HIV 风险和感染 HIV 担忧的认知。
J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19152. doi: 10.7448/IAS.17.3.19152. eCollection 2014.